Key Takeaways
- • Private equity firms have acquired more than 500 autism therapy centers over the past decade, scaling a Medicaid-dependent business model centered on Applied Behavior Analysis (ABA) services that generate revenue through intensive billable hours (30+ hours per week per client).
- • State and federal audits have identified $244.8 million in improper Medicaid payments across four states alone: Colorado ($77.8M), Indiana ($56M), Wisconsin ($94.3M), and Massachusetts ($16.7M), reflecting widespread billing documentation failures and unsupported claims.
- • Direct Medicaid payments to autism therapy providers surged to $2.2 billion in 2023 from $660 million in 2019—a 233% increase in four years—while federal Medicaid funding is projected to decline significantly, creating budget pressure on state programs already stretched by audit-identified compliance failures.
- • Consistent patterns of oversight and supervision failures across multiple state audits suggest systemic billing and care delivery management issues within PE-backed providers, raising questions about quality controls and compliance infrastructure.
Summary
Private equity's aggressive expansion into autism therapy services has created a high-growth but increasingly problematic dynamic within state Medicaid programs. Over the past decade, PE firms have acquired more than 500 autism therapy centers, positioning themselves to capitalize on explosive growth in Medicaid spending for autism services. Direct state Medicaid payments to autism therapy providers reached $2.2 billion in 2023, up from $660 million in 2019—representing growth of 233% in just four years. This expansion has been enabled by the scalable nature of Applied Behavior Analysis (ABA), the most widely used autism therapy modality, which typically requires intensive treatment schedules of 30 or more billable hours per week per client.
However, this rapid scaling has generated significant compliance and financial risk for state Medicaid programs. According to multiple state and federal audits, investigators have uncovered widespread improper payments and billing issues that point to systematic problems in how PE-backed providers manage claims. Colorado identified $77.8 million in improper payments, Indiana $56 million, Wisconsin up to $94.3 million, and Massachusetts $16.7 million. Across these audits, consistent patterns emerged: unsupported billing claims, duplicate documentation records, and broader oversight failures that raise substantive concerns about how care is actually being delivered and supervised.
The financial pressure on state budgets is intensifying at precisely the wrong moment. While Medicaid spending on autism services continues expanding, federal Medicaid funding is expected to decline significantly in coming years. This dual pressure—rising autism therapy costs coupled with expected federal budget reductions—is straining already-stretched state budgets and creating urgency around enforcement and compliance oversight. The audit findings suggest that the PE-driven scaling model, optimized for revenue growth through expanding client loads and billable hours, may have outpaced the compliance and quality assurance infrastructure necessary to ensure appropriate care and billing practices, positioning this sector as a focal point for regulatory scrutiny.
However, this rapid scaling has generated significant compliance and financial risk for state Medicaid programs. According to multiple state and federal audits, investigators have uncovered widespread improper payments and billing issues that point to systematic problems in how PE-backed providers manage claims. Colorado identified $77.8 million in improper payments, Indiana $56 million, Wisconsin up to $94.3 million, and Massachusetts $16.7 million. Across these audits, consistent patterns emerged: unsupported billing claims, duplicate documentation records, and broader oversight failures that raise substantive concerns about how care is actually being delivered and supervised.
The financial pressure on state budgets is intensifying at precisely the wrong moment. While Medicaid spending on autism services continues expanding, federal Medicaid funding is expected to decline significantly in coming years. This dual pressure—rising autism therapy costs coupled with expected federal budget reductions—is straining already-stretched state budgets and creating urgency around enforcement and compliance oversight. The audit findings suggest that the PE-driven scaling model, optimized for revenue growth through expanding client loads and billable hours, may have outpaced the compliance and quality assurance infrastructure necessary to ensure appropriate care and billing practices, positioning this sector as a focal point for regulatory scrutiny.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.